BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10942932)

  • 1. Follow-up of chimerism status after allogeneic HLA-mismatched stem cell transplantation by detection of non-shared HLA alleles.
    Gallardo D; Rodríguez-Luaces M; Aróstegui JI; Ferrá C; Berlanga JJ; Querol S; García-López J; Grañena A
    Haematologica; 2000 Aug; 85(8):848-54. PubMed ID: 10942932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing the method of chimerism monitoring after allogeneic stem cell transplantation using multiplex polymerase chain reaction amplification of short tandem repeat markers and Amelogenin.
    Sufliarska S; Minarik G; Horakova J; Bodova I; Bojtarova E; Czako B; Mistrik M; Drgona L; Demitrovicova M; Lakota J; Krivosikova M; Kovacs L
    Neoplasma; 2007; 54(5):424-30. PubMed ID: 17688372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
    Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.
    Koldehoff M; Steckel NK; Hlinka M; Beelen DW; Elmaagacli AH
    Am J Hematol; 2006 Oct; 81(10):735-46. PubMed ID: 16838323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of fluorescent in situ hybridization and multiplex short tandem repeat polymerase chain reaction for quantifying chimerism after stem cell transplantation.
    Buño I; Nava P; Simón A; González-Rivera M; Jiménez JL; Balsalobre P; Serrano D; Carrión R; Gómez-Pineda A; Díez-Martín JL
    Haematologica; 2005 Oct; 90(10):1373-9. PubMed ID: 16219574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia.
    Barrios M; Jiménez-Velasco A; Román-Gómez J; Madrigal ME; Castillejo JA; Torres A; Heiniger A
    Haematologica; 2003 Jul; 88(7):801-10. PubMed ID: 12857560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCR-based methodology for molecular microchimerism detection and quantification.
    Pujal JM; Gallardo D
    Exp Biol Med (Maywood); 2008 Sep; 233(9):1161-70. PubMed ID: 18535170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing an algorithm of informative markers for evaluation of chimerism after allogeneic bone marrow transplantation.
    Sellathamby S; Balasubramanian P; Sivalingam S; Shaji RV; Mathews V; George B; Viswabandya A; Srivastava A; Chandy M
    Bone Marrow Transplant; 2006 Apr; 37(8):751-5. PubMed ID: 16518431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capillary electrophoresis for chimerism monitoring by PCR amplification of microsatellite markers after allogeneic hematopoietic cell transplantation.
    Spyridonidis A; Zeiser R; Wäsch R; Bertz H; Finke J
    Clin Transplant; 2005 Jun; 19(3):350-6. PubMed ID: 15877797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of short tandem repeats with fluorescence labeling polymerase chain reaction to document engraftment following allogeneic bone marrow transplantation].
    Xiao L; Guo K; Chen H
    Zhonghua Xue Ye Xue Za Zhi; 2001 Aug; 22(8):418-22. PubMed ID: 11718093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.
    Lawler M; McCann SR; Marsh JC; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socié G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A;
    Br J Haematol; 2009 Mar; 144(6):933-45. PubMed ID: 19183198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation.
    Spinelli O; Giussani U; Borleri G; Lazzari M; Michelato A; Dotti G; Barbui T; Rambaldi A
    Haematologica; 2000 Nov; 85(11):1153-7. PubMed ID: 11064467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors.
    Greinix HT; Faé I; Schneider B; Rosenmayr A; Mitterschiffthaler A; Pelzmann B; Kalhs P; Lechner K; Mayr WR; Fischer GF
    Bone Marrow Transplant; 2005 Jan; 35(1):57-62. PubMed ID: 15531903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high resolution HLA class I and class II matching method for bone marrow donor selection.
    Argüello JR; Little AM; Bohan E; Gallardo D; O'Shea J; Dodi IA; Goldman JM; Madrigal JA
    Bone Marrow Transplant; 1998 Sep; 22(6):527-34. PubMed ID: 9758338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of peripheral blood stem cell transplantation from mismatched related and unrelated donors.
    Blau IW; Schmidt-Hieber M; Basara N; Hopfenmüller W; Bischoff M; Günzelmann S; Kirsten D; Schmetzer B; Roemer E; Kiehl MG; Thiel E; Fauser AA
    Clin Transplant; 2007; 21(1):110-6. PubMed ID: 17302599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting outcomes of HLA-identical allogeneic stem cell transplants from variable number of tandem repeat disparity between donors and recipients.
    Kim DH; Jung HD; Kwack DH; Lee NY; Sohn SK; Baek JH; Kim JG; Suh JS; Lee KB; Shin IH
    Haematologica; 2006 Jan; 91(1):71-7. PubMed ID: 16434373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation.
    Antin JH; Childs R; Filipovich AH; Giralt S; Mackinnon S; Spitzer T; Weisdorf D
    Biol Blood Marrow Transplant; 2001; 7(9):473-85. PubMed ID: 11669214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Variable number of tandem repeats as an evidence of engraftment status after allogeneic peripheral blood stem cell transplantation].
    Wang J; Wang J; Zhang W
    Zhonghua Yi Xue Za Zhi; 2000 Nov; 80(11):823-5. PubMed ID: 11218875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.